{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T23:05:36Z","timestamp":1762643136892,"version":"build-2065373602"},"reference-count":80,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T00:00:00Z","timestamp":1655337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["ARP-3957"],"award-info":[{"award-number":["ARP-3957"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007856","name":"Baylor College of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI150334"],"award-info":[{"award-number":["R01 AI150334"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011706","name":"National Agri-Food Biotechnology Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011706","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Methods"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.crmeth.2022.100252","type":"journal-article","created":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T04:24:57Z","timestamp":1655699097000},"page":"100252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development of an efficient reproducible cell-cell transmission assay for rapid quantification of SARS-CoV-2 spike interaction with hACE2"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8174-0251","authenticated-orcid":false,"given":"George","family":"Ssenyange","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Kerfoot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelli","family":"Farhadian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sidi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles S.","family":"Dela Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9508-0995","authenticated-orcid":false,"given":"Shaili","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard E.","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.crmeth.2022.100252_bib1","doi-asserted-by":"crossref","first-page":"e1002634","DOI":"10.1371\/journal.ppat.1002634","article-title":"Cell-cell transmission enables HIV-1 to evade inhibition by potent CD4bs directed antibodies","volume":"8","author":"Abela","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.crmeth.2022.100252_bib2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.tim.2015.02.003","article-title":"HIV cell-to-cell transmission: effects on pathogenesis and antiretroviral therapy","volume":"23","author":"Agosto","year":"2015","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.crmeth.2022.100252_bib3","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.1128\/JVI.02163-08","article-title":"The virological synapse facilitates herpes simplex virus entry into T\u00a0cells","volume":"83","author":"Aubert","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.crmeth.2022.100252_bib4","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/s41586-020-2312-y","article-title":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice","volume":"583","author":"Bao","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.crmeth.2022.100252_bib5","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3390\/v4061011","article-title":"Mechanisms of coronavirus cell entry mediated by the viral spike protein","volume":"4","author":"Belouzard","year":"2012","journal-title":"Viruses-Basel"},{"key":"10.1016\/j.crmeth.2022.100252_bib6","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1172\/JCI138745","article-title":"Deployment of convalescent plasma for the prevention and treatment of COVID-19","volume":"130","author":"Bloch","year":"2020","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.crmeth.2022.100252_bib7","doi-asserted-by":"crossref","first-page":"8801","DOI":"10.1128\/JVI.77.16.8801-8811.2003","article-title":"The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex","volume":"77","author":"Bosch","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.crmeth.2022.100252_bib8","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(20)31305-2","article-title":"Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series","volume":"396","author":"Bradley","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.crmeth.2022.100252_bib9","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1126\/science.abd9909","article-title":"De novo design of picomolar SARS-CoV-2\u00a0miniprotein inhibitors","volume":"370","author":"Cao","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.crmeth.2022.100252_bib10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cell.2020.05.025","article-title":"Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients' B cells","volume":"182","author":"Cao","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.crmeth.2022.100252_bib11","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1172\/JCI138003","article-title":"The convalescent sera option for containing COVID-19","volume":"130","author":"Casadevall","year":"2020","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.crmeth.2022.100252_bib12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/22221751.2020.1719902","article-title":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan","volume":"9","author":"Chan","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.crmeth.2022.100252_bib13","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1126\/science.abc4776","article-title":"SARS-CoV-2 infection protects against rechallenge in rhesus macaques","volume":"369","author":"Chandrashekar","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.crmeth.2022.100252_bib14","doi-asserted-by":"crossref","first-page":"12582","DOI":"10.1128\/JVI.00381-07","article-title":"Predominant mode of human immunodeficiency virus transfer between T\u00a0cells is mediated by sustained Env-dependent neutralization-resistant virological synapses","volume":"81","author":"Chen","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.crmeth.2022.100252_bib15","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1128\/JVI.80.7.3406-3415.2006","article-title":"Human chromosome 2 carries a gene required for production of infectious human immunodeficiency virus type 1","volume":"80","author":"Coskun","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.crmeth.2022.100252_bib16","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3390\/v12050513","article-title":"Protocol and reagents for pseudotyping lentiviral particles with SARS-CoV-2 spike protein for neutralization assays","volume":"12","author":"Crawford","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.crmeth.2022.100252_bib17","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1126\/science.abb8923","article-title":"Rapid COVID-19 vaccine development","volume":"368","author":"Graham","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.crmeth.2022.100252_bib18","first-page":"100041","article-title":"Seroprevalence of COVID-19 in Taiwan revealed by testing anti-SARS-CoV-2 serological antibodies on 14, 765 hospital patients","volume":"3","author":"Ho","year":"2020","journal-title":"Lancet Reg. Health West Pac."},{"key":"10.1016\/j.crmeth.2022.100252_bib19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.crmeth.2022.100252_bib20","doi-asserted-by":"crossref","first-page":"15004","DOI":"10.1038\/mtm.2015.4","article-title":"High-level production of replication-defective human immunodeficiency type 1 virus vector particles using helper-dependent adenovirus vectors","volume":"2","author":"Hu","year":"2015","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.crmeth.2022.100252_bib21","doi-asserted-by":"crossref","first-page":"609841","DOI":"10.3389\/fonc.2020.609841","article-title":"Development and validation of a simple-to-use nomogram for predicting the upgrade of atypical ductal hyperplasia on core needle biopsy in ultrasound-detected breast lesions","volume":"10","author":"Huang","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.crmeth.2022.100252_bib22","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.it.2020.04.008","article-title":"Neutralizing antibodies against SARS-CoV-2 and other human coronaviruses","volume":"41","author":"Jiang","year":"2020","journal-title":"Trends Immunol."},{"key":"10.1016\/j.crmeth.2022.100252_bib23","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/s41385-020-00340-z","article-title":"Animal and translational models of SARS-CoV-2 infection and COVID-19","volume":"13","author":"Johansen","year":"2020","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.crmeth.2022.100252_bib24","doi-asserted-by":"crossref","first-page":"12185","DOI":"10.1128\/JVI.01447-10","article-title":"Cell-cell spread of human immunodeficiency virus type 1 overcomes tetherin\/BST-2-mediated restriction in T\u00a0cells","volume":"84","author":"Jolly","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.crmeth.2022.100252_bib25","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1084\/jem.20030648","article-title":"HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse","volume":"199","author":"Jolly","year":"2004","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.crmeth.2022.100252_bib26","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1600-0854.2004.00209.x","article-title":"Retroviral spread by induction of virological synapses","volume":"5","author":"Jolly","year":"2004","journal-title":"Traffic"},{"key":"10.1016\/j.crmeth.2022.100252_bib27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41586-020-2380-z","article-title":"Human neutralizing antibodies elicited by SARS-CoV-2 infection","volume":"584","author":"Ju","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.crmeth.2022.100252_bib28","doi-asserted-by":"crossref","first-page":"e57877","DOI":"10.7554\/eLife.57877","article-title":"Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization","volume":"9","author":"Klasse","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.crmeth.2022.100252_bib29","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jmv.25685","article-title":"Coronavirus infections and immune responses","volume":"92","author":"Li","year":"2020","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.crmeth.2022.100252_bib30","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.crmeth.2022.100252_bib31","doi-asserted-by":"crossref","first-page":"104833","DOI":"10.1016\/j.phrs.2020.104833","article-title":"Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor","volume":"157","author":"Li","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.crmeth.2022.100252_bib32","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-020-2571-7","article-title":"Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike","volume":"584","author":"Liu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.crmeth.2022.100252_bib33","first-page":"e3998","article-title":"Polymerase chain reaction: basic protocol plus troubleshooting and optimization strategies","author":"Lorenz","year":"2012","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.crmeth.2022.100252_bib34","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.tips.2020.03.006","article-title":"Ongoing clinical trials for the management of the COVID-19 pandemic","volume":"41","author":"Lythgoe","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.crmeth.2022.100252_bib35","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1128\/JVI.02651-09","article-title":"Virological synapse-mediated spread of human immunodeficiency virus type 1 between T\u00a0cells is sensitive to entry inhibition","volume":"84","author":"Martin","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.crmeth.2022.100252_bib36","doi-asserted-by":"crossref","first-page":"e1000788","DOI":"10.1371\/journal.ppat.1000788","article-title":"Quantitative comparison of HTLV-1 and HIV-1 cell-to-cell infection with new replication dependent vectors","volume":"6","author":"Mazurov","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.crmeth.2022.100252_bib37","doi-asserted-by":"crossref","first-page":"e1000788","DOI":"10.1371\/journal.ppat.1000788","article-title":"Quantitative comparison of HTLV-1 and HIV-1 cell-to-cell infection with new replication dependent vectors","volume":"6","author":"Mazurov","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.crmeth.2022.100252_bib38","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-020-2607-z","article-title":"Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques","volume":"586","author":"Mercado","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.crmeth.2022.100252_bib39","doi-asserted-by":"crossref","first-page":"8360","DOI":"10.1128\/JVI.00443-10","article-title":"Virus cell-to-cell transmission","volume":"84","author":"Mothes","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.crmeth.2022.100252_bib40","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV","volume":"11","author":"Ou","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.crmeth.2022.100252_bib41","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.ymthe.2003.08.014","article-title":"Improved system for helper-dependent adenoviral vector production","volume":"8","author":"Palmer","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.crmeth.2022.100252_bib42","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/s41467-022-29288-3","article-title":"Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617","volume":"13","author":"Peng","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.crmeth.2022.100252_bib43","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.cell.2009.08.039","article-title":"Tetherin inhibits HIV-1 release by directly tethering virions to cells","volume":"139","author":"Perez-Caballero","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.crmeth.2022.100252_bib44","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41586-020-2349-y","article-title":"Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody","volume":"583","author":"Pinto","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.crmeth.2022.100252_bib45","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1038\/s41379-020-0603-3","article-title":"A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression","volume":"33","author":"Polak","year":"2020","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.crmeth.2022.100252_bib46","doi-asserted-by":"crossref","first-page":"e1009706","DOI":"10.1371\/journal.ppat.1009706","article-title":"Strategies to target SARS-CoV-2 entry and infection using dual mechanisms of inhibition by acidification inhibitors","volume":"17","author":"Prabhakara","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.crmeth.2022.100252_bib47","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1089\/104454902762053873","article-title":"Lentiviral vectors for gene delivery into cells","volume":"21","author":"Quinonez","year":"2002","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.crmeth.2022.100252_bib48","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1042\/CS20200419","article-title":"Alternative splicing of ACE2 possibly generates variants that may limit the entry of SARS-CoV-2: a potential therapeutic approach using SSOs","volume":"134","author":"Rehman","year":"2020","journal-title":"Clin. Sci."},{"key":"10.1016\/j.crmeth.2022.100252_bib49","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41586-020-2577-1","article-title":"Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing","volume":"586","author":"Riva","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.crmeth.2022.100252_bib50","doi-asserted-by":"crossref","first-page":"6234","DOI":"10.1128\/JVI.00282-09","article-title":"Simultaneous cell-to-cell transmission of human immunodeficiency virus to multiple targets through polysynapses","volume":"83","author":"Rudnicka","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.crmeth.2022.100252_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/ijp.IJP_119_20","article-title":"Therapeutic options for the treatment of 2019-novel coronavirus: an evidence-based approach","volume":"52","author":"Sarma","year":"2020","journal-title":"Indian J. Pharmacol."},{"key":"10.1016\/j.crmeth.2022.100252_bib52","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nrmicro1972","article-title":"Avoiding the void: cell-to-cell spread of human viruses","volume":"6","author":"Sattentau","year":"2008","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.crmeth.2022.100252_bib53","doi-asserted-by":"crossref","first-page":"e20201181","DOI":"10.1084\/jem.20201181","article-title":"Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses","volume":"217","author":"Schmidt","year":"2020","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.crmeth.2022.100252_bib54","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(20)31101-6","article-title":"Interferon beta-1b for COVID-19","volume":"395","author":"Shalhoub","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.crmeth.2022.100252_bib55","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1073\/pnas.2003138117","article-title":"Cell entry mechanisms of SARS-CoV-2","volume":"117","author":"Shang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.crmeth.2022.100252_bib56","doi-asserted-by":"crossref","first-page":"17146","DOI":"10.1038\/s41598-021-96462-w","article-title":"Comparative transcriptomic analysis of SARS-CoV-2 infected cell model systems reveals differential innate immune responses","volume":"11","author":"Sun","year":"2021","journal-title":"Scientific Rep."},{"key":"10.1016\/j.crmeth.2022.100252_bib57","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1089\/hum.2009.096","article-title":"Large-scale production of high-quality helper-dependent adenoviral vectors using adherent cells in cell factories","volume":"21","author":"Suzuki","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.crmeth.2022.100252_bib58","doi-asserted-by":"crossref","first-page":"e0069621","DOI":"10.1128\/mBio.00696-21","article-title":"Convalescent-phase sera and vaccine-elicited antibodies largely maintain neutralizing titer against global SARS-CoV-2 variant spikes","volume":"12","author":"Tada","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.crmeth.2022.100252_bib59","doi-asserted-by":"crossref","first-page":"103341","DOI":"10.1016\/j.isci.2021.103341","article-title":"Partial resistance of SARS-CoV-2 Delta variants to vaccine-elicited antibodies and convalescent sera","volume":"24","author":"Tada","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.crmeth.2022.100252_bib60","article-title":"Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa","author":"Tegally","year":"2020","journal-title":"Preprint at medRxiv"},{"key":"10.1016\/j.crmeth.2022.100252_bib61","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/s41586-022-04532-4","article-title":"Bat coronaviruses related to SARS-CoV-2 and infectious for human cells","volume":"604","author":"Temmam","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.crmeth.2022.100252_bib62","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/s41379-020-0536-x","article-title":"Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies","volume":"33","author":"Tian","year":"2020","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.crmeth.2022.100252_bib63","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.4155\/fmc-2020-0180","article-title":"Evidence supporting the use of peptides and peptidomimetics as potential SARS-CoV-2 (COVID-19) therapeutics","volume":"12","author":"VanPatten","year":"2020","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.crmeth.2022.100252_bib64","doi-asserted-by":"crossref","first-page":"E349","DOI":"10.1503\/cmaj.1095855","article-title":"What's next now that the WHO has declared a COVID-19 pandemic?","volume":"192","author":"Vogel","year":"2020","journal-title":"CMAJ"},{"key":"10.1016\/j.crmeth.2022.100252_bib65","doi-asserted-by":"crossref","first-page":"543147","DOI":"10.3389\/fonc.2020.543147","article-title":"A simulated dosimetric study of contribution to radiotherapy accuracy by fractional image guidance protocol of Halcyon system","volume":"10","author":"Wang","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.crmeth.2022.100252_bib66","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11684-019-0721-9","article-title":"Broadly neutralizing antibodies and vaccine design against HIV-1 infection","volume":"14","author":"Wang","year":"2020","journal-title":"Front. Med."},{"key":"10.1016\/j.crmeth.2022.100252_bib67","doi-asserted-by":"crossref","first-page":"e106057","DOI":"10.15252\/embj.2020106057","article-title":"Cholesterol 25-Hydroxylase inhibits SARS-CoV-2 and other coronaviruses by depleting membrane cholesterol","volume":"39","author":"Wang","year":"2020","journal-title":"EMBO J."},{"key":"10.1016\/j.crmeth.2022.100252_bib68","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.crmeth.2022.100252_bib69","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.crmeth.2022.100252_bib70","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.chom.2020.04.023","article-title":"Identification of human single-domain antibodies against SARS-CoV-2","volume":"27","author":"Wu","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.crmeth.2022.100252_bib71","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1038\/s41467-020-19055-7","article-title":"A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19","volume":"11","author":"Xie","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.crmeth.2022.100252_bib72","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1126\/science.abc6284","article-title":"DNA vaccine protection against SARS-CoV-2 in rhesus macaques","volume":"369","author":"Yu","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.crmeth.2022.100252_bib73","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41586-021-03431-4","article-title":"Clofazimine broadly inhibits coronaviruses including SARS-CoV-2","volume":"593","author":"Yuan","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.crmeth.2022.100252_bib74","doi-asserted-by":"crossref","first-page":"143213","DOI":"10.1172\/jci.insight.143213","article-title":"Neutralizing antibody against SARS-CoV-2 spike in COVID-19 patients, health care workers, and convalescent plasma donors","volume":"5","author":"Zeng","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.crmeth.2022.100252_bib75","doi-asserted-by":"crossref","first-page":"e01446-18","DOI":"10.1128\/JVI.01446-18","article-title":"Neutralization synergy between HIV-1 attachment inhibitor fostemsavir and anti-CD4 binding site broadly neutralizing antibodies against HIV","volume":"93","author":"Zhang","year":"2019","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.crmeth.2022.100252_bib76","doi-asserted-by":"crossref","first-page":"e1009683","DOI":"10.1371\/journal.ppat.1009683","article-title":"Rapid, reliable, and reproducible cell fusion assay to quantify SARS-Cov-2 spike interaction with hACE2","volume":"17","author":"Zhao","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.crmeth.2022.100252_bib77","doi-asserted-by":"crossref","first-page":"e53138","DOI":"10.1371\/journal.pone.0053138","article-title":"Cell-to-cell transmission can overcome multiple donor and target cell barriers imposed on cell-free HIV","volume":"8","author":"Zhong","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.crmeth.2022.100252_bib78","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.coviro.2012.11.004","article-title":"Cell-to-cell transmission of viruses","volume":"3","author":"Zhong","year":"2013","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.crmeth.2022.100252_bib79","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.7150\/ijbs.45123","article-title":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2","volume":"16","author":"Zhou","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.crmeth.2022.100252_bib80","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41586-020-2548-6","article-title":"Potently neutralizing and protective human antibodies against SARS-CoV-2","volume":"584","author":"Zost","year":"2020","journal-title":"Nature"}],"container-title":["Cell Reports Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667237522001254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667237522001254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T22:57:39Z","timestamp":1762642659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667237522001254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":80,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S2667237522001254"],"URL":"https:\/\/doi.org\/10.1016\/j.crmeth.2022.100252","relation":{},"ISSN":["2667-2375"],"issn-type":[{"type":"print","value":"2667-2375"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of an efficient reproducible cell-cell transmission assay for rapid quantification of SARS-CoV-2 spike interaction with hACE2","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crmeth.2022.100252","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}],"article-number":"100252"}}